- Home
- BELFB vs IMTX Comparison
BELFB vs IMTX Comparison
Compare BELFB & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- IMTX
- Stock Information
- Founded
- BELFB 1949
- IMTX N/A
- Country
- BELFB United States
- IMTX Germany
- Employees
- BELFB N/A
- IMTX N/A
- Industry
- BELFB
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BELFB
- IMTX Health Care
- Exchange
- BELFB Nasdaq
- IMTX Nasdaq
- Market Cap
- BELFB 1.1B
- IMTX 954.2M
- IPO Year
- BELFB N/A
- IMTX N/A
- Fundamental
- Price
- BELFB $83.78
- IMTX $6.85
- Analyst Decision
- BELFB Strong Buy
- IMTX Strong Buy
- Analyst Count
- BELFB 3
- IMTX 4
- Target Price
- BELFB $98.33
- IMTX $16.67
- AVG Volume (30 Days)
- BELFB 66.5K
- IMTX 516.6K
- Earning Date
- BELFB 02-19-2025
- IMTX 11-18-2024
- Dividend Yield
- BELFB 0.33%
- IMTX N/A
- EPS Growth
- BELFB N/A
- IMTX N/A
- EPS
- BELFB 4.32
- IMTX N/A
- Revenue
- BELFB $524,943,000.00
- IMTX $128,824,447.00
- Revenue This Year
- BELFB N/A
- IMTX $120.90
- Revenue Next Year
- BELFB $0.77
- IMTX N/A
- P/E Ratio
- BELFB $19.67
- IMTX N/A
- Revenue Growth
- BELFB N/A
- IMTX 52.53
- 52 Week Low
- BELFB $45.75
- IMTX $6.68
- 52 Week High
- BELFB $92.61
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- BELFB 52.74
- IMTX 27.51
- Support Level
- BELFB $83.00
- IMTX $6.68
- Resistance Level
- BELFB $92.61
- IMTX $7.40
- Average True Range (ATR)
- BELFB 3.50
- IMTX 0.33
- MACD
- BELFB -0.07
- IMTX -0.03
- Stochastic Oscillator
- BELFB 27.44
- IMTX 10.43
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.